Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 10Neoplasms 8Venous Thrombosis 7Pancreatic Neoplasms 5Thrombosis 4Pulmonary Embolism 4Thromboembolism 3Hemorrhage 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Venous Thormboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Stroke 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Multiple Myeloma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Leukemia 1Hemostatic Disorders 1Hematoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Bevacizumab 14Cisplatin 12Surveys and Questionnaires 11Gemcitabine 9Drug Therapy 9Standard of Care 8Nivolumab 7Cetuximab 7pembrolizumab 6S 1 (combination) 6Cyclophosphamide 6atezolizumab 5Specimen Handling 5Endoscopic Mucosal Resection 5Educational Status 5Docetaxel 5Blood Specimen Collection 5fludarabine 4aldesleukin 4Radiotherapy 4Radiosurgery 4Pemetrexed 4IFL protocol 4Folfox protocol 4Everolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastrointestinal Neoplasms × Enoxaparin × Clear all
NCT02444572 2021-07-29

ENOXACARE

Les Laboratoires des Médicaments Stériles

Phase 4 Completed
168 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡